Flavia F. Bagno

Belo Horizonte, MG, Brazil

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Corrigendum to "Safety and immunogenicity of SpiN-Tec, a T-cell based RBD-Nucleocapsid chimeric vaccine for COVID-19" [Vaccine 64 (2025) 127756].

Corrigendum to "Safety and immunogenicity of SpiN-Tec, a T-cell based RBD-Nucleocapsid chimeric vaccine for COVID-19" [Vaccine 64 (2025) 127756].

Journal: Vaccine
Published: February 12, 2026

Safety and immunogenicity of SpiN-Tec, a T-cell based RBD-Nucleocapsid chimeric vaccine for COVID-19.

Safety and immunogenicity of SpiN-Tec, a T-cell based RBD-Nucleocapsid chimeric vaccine for COVID-19.

Journal: Vaccine
Published: August 21, 2025

The LVD/NIAID/NIH MVA1974 clone as an Mpox vaccine - preclinical assessment upon in a model of lethal infection with Orthopoxvirus monkeypox in mice.

The LVD/NIAID/NIH MVA1974 clone as an Mpox vaccine - preclinical assessment upon in a model of lethal infection with Orthopoxvirus monkeypox in mice.

Journal: Vaccine
Published: July 07, 2025

Detection of IgG Antibodies Against COVID-19 N-Protein by Hybrid Graphene-Nanorod Sensor.

Detection of IgG Antibodies Against COVID-19 N-Protein by Hybrid Graphene-Nanorod Sensor.

Journal: Biosensors
Published: February 03, 2025

Dengue and SARS-CoV-2 co-circulation and overlapping infections in hospitalized patients.

Dengue and SARS-CoV-2 co-circulation and overlapping infections in hospitalized patients.

Journal: Frontiers in cellular and infection microbiology
Published: May 07, 2024

SpiN-Tec: A T cell-based recombinant vaccine that is safe, immunogenic, and shows high efficacy in experimental models challenged with SARS-CoV-2 variants of concern.

SpiN-Tec: A T cell-based recombinant vaccine that is safe, immunogenic, and shows high efficacy in experimental models challenged with SARS-CoV-2 variants of concern.

Journal: Vaccine
Published: December 12, 2023

Design, development, and validation of multi-epitope proteins for serological diagnosis of Zika virus infections and discrimination from dengue virus seropositivity.

Design, development, and validation of multi-epitope proteins for serological diagnosis of Zika virus infections and discrimination from dengue virus seropositivity.

Journal: PLoS neglected tropical diseases
Published: November 24, 2023

Quality attributes of CTVad1, a nanoemulsified adjuvant for phase I clinical trial of SpiN COVID-19 vaccine.

Quality attributes of CTVad1, a nanoemulsified adjuvant for phase I clinical trial of SpiN COVID-19 vaccine.

Journal: Nanomedicine (London, England)
Published: September 15, 2023

Evaluation of an RBD-nucleocapsid fusion protein as a booster candidate for COVID-19 vaccine.

Evaluation of an RBD-nucleocapsid fusion protein as a booster candidate for COVID-19 vaccine.

Journal: iScience
Published: August 17, 2023

SARS-CoV-2 Rapid Antigen Test Based on a New Anti-Nucleocapsid Protein Monoclonal Antibody: Development and Real-Time Validation.

SARS-CoV-2 Rapid Antigen Test Based on a New Anti-Nucleocapsid Protein Monoclonal Antibody: Development and Real-Time Validation.

Journal: Microorganisms
Published: July 12, 2023

Heterogeneity of humoral response patterns in mildly symptomatic, non-hospitalized COVID-19 patients: A one-year longitudinal study.

Heterogeneity of humoral response patterns in mildly symptomatic, non-hospitalized COVID-19 patients: A one-year longitudinal study.

Journal: Experimental biology and medicine (Maywood, N.J.)
Published: March 21, 2023

A urine-based ELISA with recombinant non-glycosylated SARS-CoV-2 spike protein for detecting anti-SARS-CoV-2 spike antibodies.

A urine-based ELISA with recombinant non-glycosylated SARS-CoV-2 spike protein for detecting anti-SARS-CoV-2 spike antibodies.

Journal: Scientific reports
Published: October 21, 2022
Showing 1-12 of 22

Last Updated: 09/26/2026